• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

Introduction to 4-(3-Isopropylureido)phenylboronic acid, pinacol ester (CAS No. 874291-02-8)

4-(3-Isopropylureido)phenylboronic acid, pinacol ester, identified by the chemical compound identifier CAS No. 874291-02-8, is a specialized boronic acid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound belongs to a class of molecules known for their utility in various biochemical interactions, particularly in the context of carbohydrate recognition and drug development. The structural motif of this compound, featuring a phenyl ring linked to a boronic acid moiety via an isopropylureido group, endows it with unique reactivity and binding properties that make it a valuable tool in synthetic and medicinal chemistry.

The pinacol ester form of the boronic acid is particularly noteworthy due to its stability under a range of conditions, which enhances its applicability in both laboratory settings and potential therapeutic applications. Boronic acids are well-known for their ability to form reversible coordination complexes with diols, making them indispensable in the development of affinity chromatography matrices and as probes for carbohydrate-protein interactions. The introduction of the isopropylureido substituent into the phenyl ring introduces additional conformational flexibility and electronic properties that can be exploited for fine-tuning binding affinities and selectivities.

Recent advancements in the field of boronic acid derivatives have highlighted their potential in modulating biological pathways involving glycosidic bonds. For instance, studies have demonstrated the utility of such compounds in inhibiting enzymes like glycosidases, which are implicated in various metabolic disorders and infectious diseases. The 4-(3-Isopropylureido)phenylboronic acid, pinacol ester (CAS No. 874291-02-8) has been explored as a lead compound in the design of novel inhibitors targeting these enzymes. Its ability to interact specifically with carbohydrate structures has opened up avenues for developing targeted therapies against pathogens that rely on glycosylation for virulence.

In addition to its role as an inhibitor, this compound has shown promise as a chiral ligand or intermediate in asymmetric synthesis. The presence of the isopropylureido group can influence the electronic environment around the boronic acid moiety, thereby affecting its coordination behavior with metal catalysts or substrates. Such properties are particularly valuable in organic synthesis where enantioselective transformations are crucial for producing biologically active molecules with high stereochemical purity.

The pharmaceutical industry has been increasingly interested in boronic acid derivatives due to their favorable pharmacokinetic profiles and reduced toxicity compared to traditional small-molecule drugs. The pinacol ester formulation of 4-(3-Isopropylureido)phenylboronic acid offers advantages such as improved solubility and stability, which are critical factors in drug development. Preclinical studies have begun to explore its potential in treating conditions associated with abnormal glycosylation, such as certain types of cancer and inflammatory diseases. The compound’s ability to selectively bind to specific carbohydrate residues on cell surfaces or extracellular matrices suggests its utility in modulating cell signaling pathways involved in these diseases.

From a synthetic chemistry perspective, the preparation of 4-(3-Isopropylureido)phenylboronic acid, pinacol ester (CAS No. 874291-02-8) involves multi-step processes that highlight modern synthetic methodologies. The introduction of the isopropylureido group requires careful control of reaction conditions to ensure high yield and purity. Advances in catalytic systems and green chemistry principles have enabled more efficient and environmentally benign routes to this compound, aligning with global efforts to sustainable chemical manufacturing.

The use of computational chemistry tools has further enhanced our understanding of the molecular interactions involving this compound. Molecular dynamics simulations and quantum mechanical calculations have provided insights into how the isopropylureido group influences the binding affinity and specificity of boronic acids towards their biological targets. These computational studies are complemented by experimental validations using spectroscopic techniques such as NMR spectroscopy and X-ray crystallography, which have confirmed the structural integrity and conformational preferences of this molecule.

The growing body of research on boronic acid derivatives underscores their versatility and importance in modern chemistry. The 4-(3-Isopropylureido)phenylboronic acid, pinacol ester (CAS No. 874291-02-8) stands out as a prime example of how modifications at specific positions within a molecular framework can lead to novel functionalities with significant biological relevance. As research continues to uncover new applications for this class of compounds, their role in drug discovery and biochemical research is expected to expand further.

• 874291-03-9(4-(3-Isobutylureido)phenylboronic acid, pinacol ester)
• 874291-00-6(4-(3-Ethylureido)phenylboronic acid, pinacol ester)
• 874297-78-6(4-(3-t-Butyllureido)phenylboronic acid, pinacol ester)
• 874291-01-7(1-Propyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea)
• 874297-80-0(4-(3-Cyclopentyllureido)phenylboronic acid, pinacol ester)
• 877134-77-5(4-(Carbamoylamino)benzeneboronic Acid Pinacol Ester)
• 874297-79-7(3-cyclopropyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea)
• 874290-94-5(4-(3-Diethylureido)phenylboronic acid, pinacol ester)
• 874290-99-0(1-Methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea)
• 850567-59-8(4-(3-Butylureido)phenylboronic acid, pinacol ester)